Publications in collaboration with researchers from Werlhof Institute (1)

2012

  1. Rozrolimupab, amixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

    Blood, Vol. 120, Núm. 18, pp. 3670-3676